Stockscreener 앱 받기
589.48
1.45%
-8.68
시간 외 거래:
587.92
-1.56
-0.26%
전일 마감가:
$598.16
열려 있는:
$602.35
하루 거래량:
1.44M
Relative Volume:
1.27
시가총액:
$61.41B
수익:
$14.21B
순이익/손실:
$4.46B
주가수익비율:
14.86
EPS:
39.68
순현금흐름:
$3.56B
1주 성능:
+1.56%
1개월 성능:
+5.09%
6개월 성능:
-15.83%
1년 성능:
-50.37%
1일 변동 폭
$585.50
$610.45
1주일 범위
$570.39
$610.45
52주 변동 폭
$476.49
$1,211.20
리제네론 파마슈티컬스 Stock (REGN) Company Profile
명칭
Regeneron Pharmaceuticals Inc
전화
(914) 847-7000
주소
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY
REGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
리제네론 파마슈티컬스 Stock (REGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-14 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-06-30 | 다운그레이드 | Argus | Buy → Hold |
| 2025-05-30 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-05-30 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-05-14 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-04-22 | 재개 | Cantor Fitzgerald | Overweight |
| 2025-02-05 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-01-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-12-10 | 재개 | BofA Securities | Underperform |
| 2024-11-15 | 개시 | Wolfe Research | Outperform |
| 2024-11-14 | 개시 | Citigroup | Neutral |
| 2024-09-24 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-03-12 | 개시 | Bernstein | Outperform |
| 2024-01-12 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Hold |
| 2023-11-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-08-21 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2023-08-21 | 재확인 | Oppenheimer | Perform |
| 2023-06-28 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2023-03-27 | 업그레이드 | SVB Securities | Market Perform → Outperform |
| 2023-03-24 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-03-23 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
| 2023-01-30 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2023-01-20 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-10-26 | 다운그레이드 | Raymond James | Mkt Perform → Underperform |
| 2022-10-17 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-09-09 | 업그레이드 | Jefferies | Underperform → Hold |
| 2022-09-09 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-07-25 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-07-13 | 개시 | Cantor Fitzgerald | Neutral |
| 2022-06-06 | 개시 | Jefferies | Underperform |
| 2022-05-23 | 개시 | SVB Leerink | Outperform |
| 2022-01-05 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-01-03 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2021-12-15 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2021-12-09 | 재개 | Wells Fargo | Overweight |
| 2021-12-07 | 재개 | Cowen | Market Perform |
| 2021-12-06 | 개시 | Goldman | Buy |
| 2021-11-19 | 재개 | BMO Capital Markets | Outperform |
| 2021-11-05 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2021-06-29 | 개시 | H.C. Wainwright | Buy |
| 2021-01-25 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2021-01-13 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2021-01-08 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-10-05 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2020-08-20 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2020-07-09 | 업그레이드 | SunTrust | Hold → Buy |
| 2020-05-26 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2020-04-28 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-04-17 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2020-04-08 | 개시 | The Benchmark Company | Hold |
| 2020-03-31 | 개시 | Wolfe Research | Peer Perform |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2020-02-26 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2020-02-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-02-25 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-02-11 | 업그레이드 | Argus | Hold → Buy |
| 2019-12-24 | 개시 | Raymond James | Mkt Perform |
| 2019-12-16 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-12-13 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-11-12 | 개시 | SunTrust | Hold |
| 2019-11-07 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-09-23 | 업그레이드 | Guggenheim | Neutral → Buy |
모두보기
리제네론 파마슈티컬스 주식(REGN)의 최신 뉴스
Regeneron Surges on FDA Delay as $0.77B Volume Ranks in Top 500 - AInvest
FDA Pushes Back Eylea HD Review; Regeneron Still Gains - Yahoo Finance
Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Scholar Rock jumps following Regeneron Eylea update - Seeking Alpha
Element Capital Management LLC Purchases New Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron's Eylea injection review dates delayed by FDA (REGN) - Seeking Alpha
Aberdeen Group plc Acquires 56,746 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Fox Run Management L.L.C. Buys Shares of 1,734 Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals Announces FDA Extension for EYLEA HD® Regulatory Submissions to Q4 2025 - Quiver Quantitative
Regeneron Says FDA Will Take More Time to Review Its Two Eylea HD Submissions - Stocktwits
FDA Extends Review Timeline: Regeneron's EYLEA HD Faces Q4 2025 Decision for Expanded Uses - Stock Titan
RWA Wealth Partners LLC Decreases Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Shares Bought by Qtron Investments LLC - MarketBeat
500 Shares in Regeneron Pharmaceuticals, Inc. $REGN Acquired by Corient IA LLC - MarketBeat
American Century Companies Inc. Purchases 14,921 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Independent Advisor Alliance Buys 472 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Shares Bought by Public Sector Pension Investment Board - MarketBeat
Kovitz Investment Group Partners LLC Buys 3,090 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Cambiar Investors LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Ethic Inc. Cuts Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Shares Bought by Fjarde AP Fonden Fourth Swedish National Pension Fund - MarketBeat
Gulf International Bank UK Ltd Sells 2,097 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
National Pension Service Grows Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Sienna Gestion Has $5.65 Million Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Stock Slumps as Trading Volume Plunges 31% to 440M Ranking 207th in U.S. Activity - AInvest
85,929 Shares in Regeneron Pharmaceuticals, Inc. $REGN Purchased by Tocqueville Asset Management L.P. - MarketBeat
Leo Keeps On Profitable Path With Solid H1 Sales Growth - insights.citeline.com
Global Ophthalmology Drugs Market to Reach USD 26.28 Billion by 2030 | MarketsandMarkets™ - GlobeNewswire Inc.
State of New Jersey Common Pension Fund D Trims Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Dimensional Fund Advisors LP Sells 15,838 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Prudential PLC - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Increases Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by E Fund Management Co. Ltd. - MarketBeat
1,038 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Bought by S Bank Fund Management Ltd - MarketBeat
Tokio Marine Asset Management Co. Ltd. Has $9.55 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Russell Investments Group Ltd. Has $93.08 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Resona Asset Management Co. Ltd. Acquires 1,225 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
How volatile is Regeneron Pharmaceuticals Inc. stockTrade Volume Report & Technical Confirmation Alerts - thegnnews.com
Regeneron Pharmaceuticals (NASDAQ:REGN) Rating Increased to Strong-Buy at Redburn Atlantic - MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) Coverage Initiated at Rothschild & Co Redburn - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Invesco Ltd. - MarketBeat
Regeneron Pharmaceuticals Inc. Building a Base Near SupportMarket Performance Summary & Growth Oriented Trading Recommendations - thegnnews.com
Cary Street Partners Financial LLC Sells 959 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron and Intellia’s Gene Therapy Study for Hemophilia B: A Potential Game Changer - TipRanks
Regeneron’s Phase 3 Study on Garetosmab: A Potential Game-Changer for FOP Treatment - TipRanks
Can Eylea HD and Dupixent Profits Revive Regeneron Stock? - Yahoo Finance
Mizuho Securities USA LLC Cuts Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) Given New $812.00 Price Target at Truist Financial - MarketBeat
리제네론 파마슈티컬스 (REGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
리제네론 파마슈티컬스 주식 (REGN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| McCourt Marion | EVP Commercial |
Nov 01 '24 |
Option Exercise |
381.40 |
1,000 |
381,400 |
13,931 |
| McCourt Marion | EVP Commercial |
Nov 01 '24 |
Sale |
844.61 |
1,000 |
844,610 |
12,931 |
2.82%
0.10%
자본화:
|
볼륨(24시간):